Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

581
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
581
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

341
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
341

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patients.

Molecular oncology·2026
Same author

Boosting the Power of Rare Variant Association Studies by Imputation Using Large-scale Sequencing Population.

Genomics, proteomics & bioinformatics·2025
Same author

Impact of Cement Distribution on the Efficacy of Percutaneous Vertebral Augmentation for Osteoporotic Fractures: Assessment with an MRI-Based Reference Marker.

The Journal of bone and joint surgery. American volume·2025
Same author

A two-phase epigenome-wide four-way gene-smoking interaction study of overall survival for early-stage non-small cell lung cancer.

Molecular oncology·2024
Same author

Associations of ambient air pollution and lifestyle with the risk of NAFLD: a population-based cohort study.

BMC public health·2024
Same author

Checkpoint Kinase 1 Stimulates Endogenous Cardiomyocyte Renewal and Cardiac Repair by Binding to Pyruvate Kinase Isoform M2 C-Domain and Activating Cardiac Metabolic Reprogramming in a Porcine Model of Myocardial Ischemia/Reperfusion Injury.

Journal of the American Heart Association·2024

相关实验视频

Updated: Jan 18, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K

对于罕见疾病临床试验的贝叶斯序列决策.

Yuan Gao1, Jianling Bai1, Feng Chen1

  • 1Department of Biostatistics, School of Public Heath, Nanjing Medical University, Nanjing, China.

Technology and health care : official journal of the European Society for Engineering and Medicine
|May 29, 2025
PubMed
概括

这项研究引入了贝叶斯对罕见疾病临床试验的序列设计. 它允许更早地停止对优越性或徒劳性的试验,节省时间,成本,并防止患者暴露在无效治疗中.

科学领域:

  • 临床试验 临床试验
  • 生物统计学 生物统计学
  • 药物开发 药物开发

背景情况:

  • 罕见病临床试验面临重大挑战,包括小患者群体和避免徒劳治疗的伦理需要.
  • 传统的固定样本试验设计对于罕见疾病往往是低效的.
  • 贝叶斯序列设计提供了一种动态方法,以优化不确定性下的决策.

研究的目的:

  • 为罕见疾病的临床试验提出和评估一个新的贝叶斯序列设计框架.
  • 根据不断积累的证据,使试验能够更早,更有效地结束.
  • 为了减少样本大小,持续时间和成本,同时确保患者安全和可解释的结果.

主要方法:

  • 连续贝叶斯因子分析与二进制终点的自适应性停止规则的集成.
  • 利用贝叶斯后置概率来确定优势或徒劳的早期终止值.
  • 应用贝叶斯因子设计分析以确保试验可行性并指导临时决策.

主要成果:

  • 拟议的贝叶斯序列设计为证明有效性 (优越性) 和缺乏有效性 (徒劳性) 的早期试验终止提供了便利.
  • 可以大大减少样本规模,试验持续时间和财务支出.
  • 患者暴露于缺乏有效性的治疗方法是最小化的,从而提高了伦理试验的进行.
关键词:
贝叶斯因子是一个贝叶斯因子.贝叶斯因子设计分析 设计分析贝叶斯的顺序决策是贝叶斯式的.序列贝叶斯因子测试测试罕见疾病 临床试验 罕见疾病 临床试验

更多相关视频

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

相关实验视频

Last Updated: Jan 18, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

结论:

  • 贝叶斯序列设计加快了在罕见疾病中治疗疗效的确认,允许迅速结束试验.
  • 这种方法优化了资源配置,并通过避免长时间接触无益疗法来提高患者福利.
  • 促进贝叶斯式顺序决策可以加快罕见病药物批准和市场准入.